These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 20852399)

  • 1. Dermal fillers: help patients put their best face forward.
    Czerkasij V
    Nurse Pract; 2010 Oct; 35(10):43-7. PubMed ID: 20852399
    [No Abstract]   [Full Text] [Related]  

  • 2. Erasing the years. An overview of dermal fillers.
    De Silva LW
    Adv Nurse Pract; 2006 Feb; 14(2):31-3. PubMed ID: 16471304
    [No Abstract]   [Full Text] [Related]  

  • 3. Multicenter, randomized, parallel-group study of the safety and effectiveness of onabotulinumtoxinA and hyaluronic acid dermal fillers (24-mg/ml smooth, cohesive gel) alone and in combination for lower facial rejuvenation.
    Carruthers A; Carruthers J; Monheit GD; Davis PG; Tardie G
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2121-34. PubMed ID: 21134044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicenter, randomized, parallel-group study of onabotulinumtoxinA and hyaluronic acid dermal fillers (24-mg/ml smooth, cohesive gel) alone and in combination for lower facial rejuvenation: satisfaction and patient-reported outcomes.
    Carruthers J; Carruthers A; Monheit GD; Davis PG
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2135-45. PubMed ID: 21070457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How to achieve synergy between volume replacement and filling products for global facial rejuvenation.
    Raspaldo H; Aziza R; Belhaouari L; Berros P; Body S; Galatoire O; Le Louarn C; Michaud T; Niforos F; Rousseaux I; Runge M; Taieb M
    J Cosmet Laser Ther; 2011 Apr; 13(2):77-86. PubMed ID: 21401381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incorporating facial rejuvenation procedures in the dental practice.
    Roberts W
    Todays FDA; 2013; 25(2):50-3. PubMed ID: 23691617
    [No Abstract]   [Full Text] [Related]  

  • 7. Botulinum toxin type A for aging face and aesthetic uses.
    Hexsel C; Hexsel D; Porto MD; Schilling J; Siega C
    Dermatol Ther; 2011; 24(1):54-61. PubMed ID: 21276158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Juvéderm: a hyaluronic acid dermal filler.
    Monheit GD; Prather CL
    J Drugs Dermatol; 2007 Nov; 6(11):1091-5. PubMed ID: 18038495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Saving face. Strategies to fight father time.
    Cobb C
    Adv Nurse Pract; 2009 Apr; 17(4):39-43, 68. PubMed ID: 20014725
    [No Abstract]   [Full Text] [Related]  

  • 10. Surfing the Internet on nonsurgical rejuvenation: focus on dermal fillers and botox cosmetic.
    Sagrillo DP; Kunz S
    Plast Surg Nurs; 2005; 25(2):111-4. PubMed ID: 15983504
    [No Abstract]   [Full Text] [Related]  

  • 11. Skin fillers.
    Kusin S; Lippitz J
    Dis Mon; 2009 Apr; 55(4):236-56. PubMed ID: 19286057
    [No Abstract]   [Full Text] [Related]  

  • 12. Overview of skin aging and photoaging.
    Helfrich YR; Sachs DL; Voorhees JJ
    Dermatol Nurs; 2008 Jun; 20(3):177-83; quiz 184. PubMed ID: 18649702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current concepts in lip augmentation.
    Mannino GN; Lipner SR
    Cutis; 2016 Nov; 98(5):325-329. PubMed ID: 28040807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversible vs. nonreversible fillers in facial aesthetics: concerns and considerations.
    Smith KC
    Dermatol Online J; 2008 Aug; 14(8):3. PubMed ID: 19061563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Making the right choices: attaining predictable aesthetic results with dermal fillers.
    Beer K; Lupo MP
    J Drugs Dermatol; 2010 May; 9(5):458-65. PubMed ID: 20480788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What's new with hyaluronic acid fillers.
    Gold MH
    J Drugs Dermatol; 2007 Oct; 6(10):1050-3. PubMed ID: 17966186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 'liquid' facelift.
    Grasso MJ
    Adv Nurse Pract; 2009 Nov; 17(11):19. PubMed ID: 20014685
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of Botulinum Toxin and Hyaluronic Acid Filler to Treat Oral Involvement in Scleroderma.
    Cumsky HJL; Pham MM; Hoss E
    Dermatol Surg; 2022 Jun; 48(6):698-699. PubMed ID: 35333209
    [No Abstract]   [Full Text] [Related]  

  • 19. Fillers and the "three curves of youth".
    Fitzgerald R
    J Drugs Dermatol; 2012 Aug; 11(8):s9-11; discussion s11. PubMed ID: 22859223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. International consensus recommendations on the aesthetic usage of botulinum toxin type A (Speywood Unit)--Part II: Wrinkles on the middle and lower face, neck and chest.
    Ascher B; Talarico S; Cassuto D; Escobar S; Hexsel D; Jaén P; Monheit GD; Rzany B; Viel M
    J Eur Acad Dermatol Venereol; 2010 Nov; 24(11):1285-95. PubMed ID: 20569284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.